Searchable abstracts of presentations at key conferences in endocrinology

ea0090p259 | Thyroid | ECE2023

Male with Graves Disease and Primary Thyroid Cancer in the Thyroglossal Cyst

Logwin Sergio , Ruiz Diaz Daisy , Jimenez Violeta , Bueno Elvio , Romero Fabiola

Introduction: The malignancy of the thyroglossal duct cyst is infrequent, 0.7 to 1% of the thyroglossal duct cysts, predominantly in women and euthyroid subjects, some associated with Hashimoto’s Thyroiditis. Clinical case: Male, 42 years old, with a 5-year history of a large anterior cervical tumor, diagnosed with Graves’ disease and thyroid orbitopathy. Cervical ultrasound reports right submandibular region mixed tumor mass 36 x30. mm with no...

ea0013p135 | Diabetes, metabolism and cardiovascular | SFEBES2007

US Mexico border diabetes prevention and control project

Ruiz Rosalba , Diaz-Kenney Rita , Lara Agustin

The USMBDPCP is unique that it is the first study to consider the whole US- Mexico Border as one epidemiological unit. The project goal is to reduce the burden of diabetes among persons with type 2 diabetes living in the U.S.-Mexico border region. I Development of a Prevalence Study and identification of risk factors. II Implementation an intervention pilot study for diabetes prevention and control.Phase IThe diabetes prevalence su...

ea0099rc4.3 | Rapid Communications 4: Diabetes, Obesity, Metabolism and Nutrition | Part I | ECE2024

Irrespective of diet composition, cycles of low-calorie intake imprint a unique hepatic signature throughout the secretome to influence organismal energy balance

Lopez-Canovas Juan Luis , Naranjo-Martinez Beatriz , DIaz-Ruiz Alberto

Identifying effective strategies and underneath molecular signatures is crucial to combat certain metabolic diseases with increasing incidence such as obesity and MASLD (metabolic dysfunction-associated steatotic liver disease). The hepatic secretome plays a crucial role at controlling global energy metabolism and inflammation in MASLD. However, the interplay between diet composition and the eating architecture on the dynamic response of secretome as a tool to improve disease ...

ea0029p1266 | Obesity | ICEECE2012

Proteomic analysis of adipose tissue in health and disease

Malagon M. , Guzman-Ruiz R. , Diaz-Ruiz A. , Vazquez-Martinez R. , Lopez-Miranda J. , Tinahones F. , Peinado-Mena J.

Adipose tissue is a highly active metabolic organ which, together with its role as an energy storage depot, produces a wide variety of bioactive molecules (i.e. adipokines) with important roles in the regulation of energy metabolism and homeostasis, immunity and inflammation. Alterations in lipid metabolism and/or in adipokine production associated to the excess of adipose tissue that defines obesity or to adipose tissue deficiency, as occurs in lipodystrophy, are linked to in...

ea0032p683 | Neuroendocrinology | ECE2013

The small GTPase Rab18 modulates neuroendocrine secretion by interacting with components of the microtubule-based secretory granule transport machinery

Vazquez-Martinez Rafael , Almabouada Farid , Rabanal Yoana , Diaz-Ruiz Alberto , Garcia-Navarro Socorro , Malagon Maria M

Several Rab proteins control secretory granule trafficking and, hence, hormone release, by regulating the activity of different components of the secretory granule transport machinery. Particularly, Rab18 inhibits secretory granule movement, which leads to reduced neuropeptide and hormone secretion in PC12 pheochromocytoma cells and ACTH-secreting ATt20 cells, respectively, but how this GTPase accomplishes its role and the identity of the proteins that regulate Rab18 activity ...

ea0037ep375 | Diabetes (pathiophysiology & epitemiology) | ECE2015

Evaluation of quality indicators in hospital discharge reports in diabetic patients from an Internal Medicine Service: are we doing a good clinical practice?

Varela-Aguilar Jose M , Teran-Redondo Rafael , Calero-Bernal Maria Luz , Calzada-Valle Ana , Garcia-Contreras Rosa , Pereira-Diaz Estefania , Moreno-Verdejo Fidel , Ruiz-Ruiz Francisco , Calderon-Sandubete Enrique

Spanish Scientific Societies involved in diabetic patient care produced a consensus document with recommendations and quality indicators for hospital discharge reports (HDR).Objective: To analyse adequacy of HDR in diabetic patients from an Internal Medicine Service according to these recommendations (Med Clin (Bar) 2012 138 666.e1–666.e10).Methods: Study based on a programme continuity of care among ...

ea0037ep1330 | Clinical Cases–Thyroid/Other | ECE2015

Diabetes, obesity and psoriasis in a 60-year-old woman

Varela-Aguilar Jose M , Garcia-Contreras Rosa , Calzada-Valle Ana , Calero-Bernal M Luz , Pererira-Diaz Estefania , Moreno-Verdejo Fidel , Hurtado-Ganoza Abelardo , Ruiz-Ruiz Francisco , Calderon-Sandubete Enrique

Psoriasis (PS) is a skin disease of immune T-cell mediated. It is well known that obesity is a risk factor for severity PS and PS is associated with the degree of overweight. In addition, patients with PS have increased risk of metabolic disorders such as diabetes mellitus (DM) and dyslipidaemia. All these processes are characterised by the presence of systemic chronic inflammation. Liraglutide, an agonist receptor GLP-1, is being used in the treatment of obesity and diabetes ...

ea0081ep291 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Description of patients with diabetic foot of neuropathic and vascular cause cared for in a multidisciplinary Diabetic Foot Unit

Pinar Gutierrez Ana , Gros-Herguido Noelia , Losada-Vinau Fernando , Farfan-Diaz Fatima , Enriquez-Perez Monica , Ruiz-Trillo Carmen , Ciuro Felipe Pareja , Fuentes Lucas Mengibar , Soto-Moreno Alfonso

Objective: 6% of people with diabetes present with diabetic foot as a complication, which means greater morbidity and mortality compared to those who do not. Its diagnosis and management by multidisciplinary teams including surgeons can improve these patients’ care. The objective was to analyze the main characteristics of patients and health results obtained, as well as to evaluate the impact of PAD (peripheral artery disease) existence in patients cared for in our multid...

ea0049ep715 | Obesity | ECE2017

Lifestyle of morbidly obese patients awaiting bariatric surgery and in the cohort of patients who have undergone surgery

Mateo-Gavira Isabel , Medina-Rivero Daniel , Rodriguez-Martin Amelia , Novalbos-Ruiz Jose Pedro , Santi-Cano Maria Jose , Diaz-Yelamos A , Aguilar-Diosdado Manuel

Objectives: To determine the habits and lifestyle of the morbidly obese before and after bariatric surgery.Material and methods: Transversal study of two groups of morbidly obese patients attending the Endocrinology Unit of Puerta del Mar, Cádiz: one group before and the other after bariatric surgery. Clinical and analytical data of the patients was collected: socio-demographic and lifestyle characteristics, Bulit-R Questionnaire (Bulimia), BIS (imp...

ea0041ep597 | Endocrine tumours and neoplasia | ECE2016

Phaeochromocytomas and paragangliomas: A comparative study between sporadic and familial cases in a reference care center in Spain

Luis Guillermo Ropero , Perez Jose Angel Diaz , Gracia Teresa Ruiz , Hernandez Martin Cuesta , Hoyos Emilia Gomez , Hernandez Irene Crespo , Novoa Paz de Miguel

Introduction: Hereditary phaeochromocytoma (PCC) and paraganglioma (PGL) account for 30–35% of cases and have some clinically relevant peculiarities.Material and methods: Retrospective, unicentric cohort study that included all genotyped patients (n=36, 27 with PCC and 9 with PGL) diagnosed at Hospital Clínico San Carlos (Madrid) between 1984 and 2013; 33% were germline mutation carriers (25% pseudohypoxic [PH] phenotype, 75% MAP-kinas...